Quick Answer
BetterLife Pharma Inc. reported Operating Income Loss of -$6.84 million for the year ending 2019.
- BetterLife Pharma Inc. showed a decrease of -405.1% in Operating Income Loss from 2018 to 2019.
- This data is from BetterLife Pharma Inc.'s annual report (Form 10-K), filed with the SEC on May 3, 2019.
- XBRL data for this metric is available from 2015 to 2019 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2015 to 2019), BetterLife Pharma Inc.'s Operating Income Loss has declined by 5,725.6%.
- Historical annual values: Fiscal year 2019: -$6.84 million | Fiscal year 2018: -$1.35 million | Fiscal year 2017: -$6.02 million | Fiscal year 2016: -$10.32 million | Fiscal year 2015: -$117.5 thousand.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: